作者
Jeremy N Rich, David A Reardon, Terry Peery, Jeannette M Dowell, Jennifer A Quinn, Kara L Penne, Carol J Wikstrand, Lauren B Van Duyn, Janet E Dancey, Roger E McLendon, James C Kao, Timothy T Stenzel, BK Ahmed Rasheed, Sandra E Tourt-Uhlig, JE Herndon 2nd, James J Vredenburgh, John H Sampson, Allan H Friedman, Darell D Bigner, Henry S Friedman
发表日期
2004/1/1
期刊
Journal of Clinical Oncology
卷号
22
期号
1
页码范围
133-142
出版商
WB SAUNDERS CO
简介
Purpose
To evaluate the efficacy and tolerability of gefitinib (ZD1839, Iressa; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
引用总数
学术搜索中的文章
JN Rich, DA Reardon, T Peery, JM Dowell, JA Quinn… - Journal of Clinical Oncology, 2004